News

Date

We are pleased to announce that a Parkinson's research project has been awarded the inaugural BenevolentAI Award. The project will use an artificial intelligence platform's capabilities to reason, deduce and suggest entirely new treatments for Parkinson's. 

Date

We're partnering with US company Neurolixis to accelerate the development of a drug that could prevent dyskinesia, a debilitating side effect of Parkinson's medication.

Date

It's one year on and our Live Loud! volunteers in Wales continue to make a real difference to people whose voices have been affected by Parkinson's.